Vijaya Diagnostic Center Limited IPO Details

Dates, Price band, Lot size, Risks, Review and broker recommendations etc.
Vijaya Diagnostic IPO

Vijaya Diagnostic IPO: Key Details

  • Grey Market Premium (GMP) today: TBD

Note: We neither trade nor encourage our readers to trade in the Grey Market. We share the GMP information for educational purposes only, so that, you can make an informed decision.

Company Information

Vijaya Diagnostic Center Limited, incorporated in 1981, is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chain by revenue for fiscal year 2020.

They offer a one-stop solution for pathology and radiology testing services to customers through its extensive operational network, which consists of 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata as on June 30, 2021.

They offer a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines.

Competitive Strengths

  • Largest and fastest growing diagnostic chain with dominant position in South India, Well positioned to keverage the high growth in Indian diagnostics industry
  • Integrated diagnostics provider that offers One-Stop Solution at affordable price
  • High Brand Recall and commitment to superior quality driving ighh individual consumer ubsiness share and customer stickiness
  • Robust technical capability and state of the art technology with strong IT Infrastructure
  • Long track record of delivering consistent profitable growth, with strong cash generation and return metrics
  • Dedicated management team with significant industry experience

Company Strategy

  • Deepen Footprint in the Core Markets
  • Leveraging existing presence by focusing on setting up spoke centres and increasing home collection in existing catchment areas
  • Continue to focus on providing customer centric services and offerings
  • Expand in adjacent geographies and east India
  • Supplement organic Ggrowth with selective acquisitions

Proceeds from Vijaya Diagnostic IPO will be used to:

The Company will not directly receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer

Vijaya Diagnostic IPO: Financials

201920202021 Mar2021 June
Revenue from Ops₹292.59 Cr₹332.82 Cr₹376.75 Cr₹122.67 Cr
Profit before Excep*₹65.32 Cr₹83.43 Cr₹112.12 Cr₹44.21 Cr
Profit after Tax46.27 Cr₹62.51 Cr₹84.91 Cr₹33.92 Cr
EPS (Basic)4.506.138.263.23
*Tax and Exceptional Items
As of March 2020EPS (Avg*)P/E (Floor)P/E (Cap)
Based on basic EPS6.9275.4376.73
* Weighted Average for last 3 years

Vijaya Diagnostic IPO: Comparison with listed industry peers

CompanyP/E (Cap)
Vijaya Diagnostic76.73
Highest (Dr. Lal Path Labs)107.3
Lowest (Metropolis Healthcare)74.4

Vijaya Diagnostic IPO Dashboard

Issue Details

TypeValue
Issue Size₹1,895.04 Cr
Offer for Sale₹1,895.04 Cr
Face Value₹1/- per Equity Share
IPO Price₹522 – ₹531
Lot Size 28 shares
LotsMin 1 – Max 13

Key Dates

Date TypeDate
Bid Open1/09/2021
Bid Close3/09/2021
Allotment Finalization8/09/2021
Initiation of Refunds9/09/2021
Credit of Shares13/09/2021
Listing Date14/09/2021

Lot Size and Price

LotsSharesAmount
128₹14,868
13364 ₹1,93,284

Promoter Holding

HoldingPercentage
Pre-Issue59.78%
Post-Issue54.78%

Vijaya Diagnostic IPO: Investor Quota and Shares Offered

Investor TypeQuotaShares on Offer
QIB50%[●] shares
NII15%[●] shares
RII (Retail)35%[●] shares
Total100%[●] shares

Vijaya Diagnostic IPO: Risks

  • The CEO, Sura Suprita Reddy was named in a criminal proceeding
  • Any interruptions at the flagship centre and other diagnostic centres may adversely the business
  • One of our Subsidiaries MDSL was in non-compliance of the Listing Regulations in the past which have since been rectified
  • There are outstanding legal proceedings involving the Company, Subsidiaries and Directors which may adversely affect business
  • The Group Companies have incurred losses in the past and may incur losses in the future

For complete internal and external risk factors, you can refer to the RHP of the company.

Vijaya Diagnostic IPO: Registrar and Lead Managers

Registrar of the Issue

KFintech (Formerly Karvy)

Selenium Tower B, Plot 31 & 32,
Financial District, Nanakramguda, Serilingampally Mandal,
Hyderabad, Telangana India – 500 032.

Phone: 1-800-309-4001
Email: [email protected]

Lead Managers of the Issue

ICICI Securities Limited
Edelweiss Financial Services Limited
Kotak Mahindra Capital Company Limited

Phone: +91 22 2288 2460
Email: [email protected]

Leave a Reply

3 + 20 =

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.